DIA India’s 7th Annual Conference Discovery through Commercialization: Innovative Strategies for Individualized Healthcare

There are only 4 days left to register for India’s most informative and dynamic meeting on the pharmaceutical industry!

DIA India’s 7th Annual Conference Discovery through Commercialization: Innovative Strategies for Individualized Healthcare, being held at the Hyderabad  International Convention Center Novotel & HICC Complex on November 1-4 is shaping up to be a ‘can’t-miss event.’ 

This 2012 conference will focus on the discovery, development, manufacturing and commercialization to generate ground-breaking approaches to personalized health care. We are proud to present Keynote Addresses from Paul Huckle, Senior Vice President, Global Regulatory Affairs, GlaxoSmithKline and Adrian McKemey, Practice Leader, Product Development & Commercialization, Quintiles.

For Rs9000.00 for 3 days you will network with global colleagues, hear from top leaders, and choose from over 26
interactive sessions. Click here to view the conference program with over 75 International & India industry leaders.

There are only a few days left to  for DIA India’s 7th Annual Conference- we are looking forward to seeing you there!

For more information and group registrations please contact Manoj.Trivedi@diaindia.org or call +91.98.2058.7798.

  Register Online     Read More

Follow us and tweet on the 7th Annual Conference with #DIAIndiaAM2012

DIA INDIA 7th Annual Conference - November 1-4 Hyderabad

Listen to Paul Huckle & Adrian McKemey - Keynote Speakers at 7th Annual Conference KEYNOTE SPEAKER 1 Paul Huckle Senior Vice President Global Regulatory Affairs GlaxoSmithKline   KEYNOTE SPEAKER 2 Adrian McKemey Practice Leader, Product Development & Commercialization Quintiles The 7th Annual Conference this year will begin with Keynote Addresses from Paul Huckle, Senior Vice President, Global Regulatory Affairs, GlaxoSmithKline and Adrian McKemey, Practice Leader, Product Development & Commercialization, Quintiles. The three day conference through 25 sessions and 3 tutorials on the theme 'Innovative Strategies for Individualized Health Care' will bring together regulators and pharma professionals working in the discovery, development, manufacturing or commercialization fields, academicians working in the fields related to the healthcare industry, finance professionals working in the healthcare sector and patient advocacy groups. To know more on the conference program here are a few session details.   Scientific, Regulatory and Ethical Challenges in Advancing Personalized Medicine  This session chaired by Carol Isaacson Barash, Principal, Helix Health Advisors, Adjunct Prof. Personalized Medicine, Regis College will discuss Realizing the Promise of Personalization through Healthcare Mass Commercialization by Sagar Kamarthi, Associate Professor, Department of Mechanical and Industrial Engineering, Northeastern University, Boston Regulatory Challenges for Molecular and Companion Diagnostics by Jeffrey N. Gibbs, Director Hyman, Phelps & McNamara, P. C. Ethical Issues in Individualized Health Care — Seeking Solutions in a Complex World by Aamir Shaikh, Founder Assansa Personalized Nutrition: Parallels from Personalized Medicine by Emanuelle Voisin, CEO and Principal, Voisin Consulting   Register Online      Read More Therapeutics — Pharmacology and Applications in Personalise Medicine This session chaired by Vishwas Sovani, Country Manager, Revogenex, Inc. will discuss Personalised Medicine Pharmacological basis by Vishwas Sovani, Country Manager, Revogenex, Inc. Therapeutic Applications of Personalized Medicine by Mangesh Kulkarni, Group Head, DS&E Novartis Healthcare Ready to use Kits for Personalized Medicine by Mukesh Agrawal, Vice President - CRL, Vimta Labs   Register Online      Read More Personalized Precision Medicine: Regulatory, Financial and Ethical Challenges to Ensuring its Growth  This panel chaired by Carol Isaacson Barash, Principal, Helix Health Advisors, Adjunct Prof. Personalized Medicine, Regis College will consist of the following panelists Jeffrey N. Gibbs, Director, Hyman, Phelps & McNamara, P. C. Arun Mishra, Director, Global Regulatory Affairs, Asia-Pacific, Japan, Emerging Markets, GlaxoSmithKline Shoibal Mukherjee, Vice President and Head, Asia Medical Sciences Group, Quintiles Nandini K. Kumar, Former Deputy Director General, Sr. Grade Investigator NIH project, National Institute of Epidemiology Femida Gwadry-Sridhar, Director, Health Informatics, Lawson Health Research Institute Sagar Kamarthi, Associate Professor, Department of Mechanical and Industrial Engineering Northeastern University, Boston   Register Online     Read More 7th Annual Conference Registration Fees Reduced Registration fees at the 7th Annual Conference have been reduced by nearly 20% to as low as Rs. 9,000 + taxes to help the industry participate in large numbers and gain immensely through this unique networking opportunity. Click here to view the conference program with over 75 International & India industry leaders. For more information and group registrations please contact Rhean.DSouza@diaindia.org or call +91.98.2058.7798. Follow us and tweet on the 7th Annual Conference with #DIAIndiaAM2012   Register Online      Read More Thank You to our 7th Annual Conference Supporters Level 2 Level 1 Email Preferences    |    My DIA    |    Forward to a Friend    |

Innovative Strategies for Individualized Health Care (Hyderabad) - last 3 wks to register

Last 3 Weeks To Register - 7th Annual Conference The 7th Annual Conference this year through 25 sessions and 3 tutorials on the theme 'Innovative Strategies for Individualized Health Care' will bring together regulators and pharma professionals working in the discovery, development, manufacturing or commercialization fields, academicians working in the fields related to the healthcare industry, finance professionals working in the healthcare sector and patient advocacy groups. To know more on the conference program here are a few session details.   Lead Discovery  This session chaired by Raman Govindarajan, Head R&D, Sanofi will discuss Impact of Structural Biology on Drug Discovery by Ajith Kamat, Head, Strategic Research Partnerships, Pfizer Lead Identification and Optimization in Small Molecular Drug Discovery: SBDD Case Studies byVellarkad N. Viswanadhan,  Vice President, Jubilant Biosys Application of Parallel Medicinal Chemistry Strategies for Rapid and Efficient Optimization of Adenosine A1 Receptor Modulators by Venkata Palle, Vice President - Discovery Research Novel Drug Discovery and Development, Lupin   Register Online      Read More Product and Pricing Strategy and Payor Challenges This session chaired by R. B. Smarta, Founder and Managing Director, Interlink Marketing Consulting will discuss Sizing the Opportunity, Market Driven Commercialization of Products by Dhananjay Bhakhle, Executive Vice President, Medical Research, Lupin Pharmaceuticals Pricing Strategy in Indian Context by Anil Kamath, Founder Chairman, Esemcee Advisors Using Real World Evidence to Drive Access Strategies by Simu Thomas, Global Head, Economic Modeling, Global Medical Affairs and HEOR Novartis, USA   Register Online      Read More Evolving Roles of Personnel Involved in Clinical Trials:  Panel Discussion  This panel chaired by Sam Mathew, Process Lead-Medical Writing, Accenture Services will consist of the following panelists Ajit Nair, Global Head - Clinical Services, Tata Consultancy Services Partha Chakraborthy, Senior Director & Global Delivery Head, R&D, Cognizant Technology Solutions Anish Desai, Director Medical Affairs and Clinical Operations, Johnson & Johnson S Sinha, Head (Global) & Associate Vice President, Clinical Development & Medical Affairs (CD&MA), Hetero Group   Register Online     Read More 7th Annual Conference Registration Fees Reduced Registration fees at the 7th Annual Conference have been reduced by nearly 20% to as low as Rs. 9,000 + taxes to help the industry participate in large numbers and gain immensely through this unique networking opportunity. Click here to view the conference program with over 75 International & India industry leaders. For more information and group registrations please contact Rhean.DSouza@diaindia.org or call +91.98.2058.7798. Follow us and tweet on the 7th Annual Conference with #DIAIndiaAM2012   Register Online      Read More

Flexible Manufacturing Solutions To Adapt To The Evolving Industry Scenario - Hyderabad, India

The 7th Annual Conference offers attendees a numbers of sessions specifically focusing on catering to manufacturing. To help the manufacturing industry DIA is offering a special 2 day registration fee. This can be availed by others as well. Details of these sessions are mentioned below.   Manufacturing - Session 12 - November 3, 2012  This session chaired by SC Singhai, Vice President - Tech Transfer, Dr. Reddy’s will discuss Potent Product Process and Facility Design by SC Singhai,Vice President - Tech Transfer, Dr. Reddy’s Quality Management Process in Faculty Development by Vinay Nayak, President, Alembic Pharmaceuticals World Class Manufacturing- A Challenge and Opportunity for the Indian Pharma Industry by Pushpinder Bindra, CEO, Zenith and Beyond Case Study: Integration of Patient Needs, and Quality Requirements in Recent Times has Enforced Application of “Quality by Design (QbD)” and “Process Analytical Technology (PAT)” to development of Therapeutic Vaccines by Nicolas Cappuccino, Global Head, Quality,  Dr. Reddy’s   Register Online      Read More Manufacturing - Session 15 - November 3, 2012 This session chaired by Subir Basak, President, Jubilant Biosys will discuss Pharmacogenomics for Personalized Medicine: Optimizing use of Drug and Drug Combinations to Improve Patient Outcome by Jugnu Jain, Director, Saarum Siences Quality Control, a Necessary Paradigm when “Leaning Out” Operations, as Pharmaceuticals Shift from the Blockbuster Model to Personalized Gene Therapies and Gene-specific Small-molecule Treatments by Swapnil Baghel, Quality Lead, Biocon BioManufacturing in India by Subir Basak, President, Jubilant Biosys   Register Online      Read More 7th Annual Conference Registration Fees Reduced Registration fees at the 7th Annual Conference have been reduced by nearly 20% to as low as Rs. 9,000 + taxes to help the industry participate in large numbers and gain immensely through this unique networking opportunity. Click here to view the conference program with over 75 International & India industry leaders. For more information and group registrations please contact Rhean.DSouza@diaindia.org or call +91.98.2058.7798. Follow us and tweet on the 7th Annual Conference with #DIAIndiaAM2012   Register Online      Read More Email Preferences    |    My DIA    |    Forward to a Friend    |